Global Community

Main Driver of Recent Growth The company has delivered impressive performance—its annual EPS growth over the past three years averaged around 37% , while EBIT margin surged from roughly 9% to 23% , signaling strong operational leverage and expansion in profitability How Catalysts Support the Growth Trend Forecasts point to continued momentum—analysts expect earnings to grow at an estimated ~27% per annum , underscoring sustained traction. Additionally, comparison to peers shows a lower P/E (33.4× vs.

Main Driver of Recent Growth Palomar has delivered standout performance, with earnings growing ~61% YoY and revenue rising ~53% YoY , underscoring exceptional underwriting execution and demand momentum in specialty lines. How Catalysts Support the Trend Strong Q2 2025 results further reinforce momentum: revenue up 55% YoY and net income up 81% YoY ; earnings and revenues beat analyst expectations by ~16% and ~5% respectively.

If earnings hit half of what they were when the company founded in 2016, which was a reasonable housing market period, the company will profit around half a billion SEK. With a P/E multiple of 14, that is around 7 billion sek, which is 3 times the current market value.

1. Cybersecurity Is Non-Negotiable Fortinet isn’t optional.

What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.

Ticker : ZGSE:KOEI | Sector : Industrials | Market Cap : ~1.50B EUR | Current Price : 584.00 EUR (July 2025) | Estimated Fair Value : 1,146.52 EUR Why Invest in KONČAR Group? KONČAR Group (KOEI), a leading Croatian industrial conglomerate specializing in electrical equipment, renewable energy, and urban mobility, is significantly undervalued, offering ~96% upside to a conservative fair value of 1,146.52 EUR.

1. Platform Model: Mobility, Delivery & Logistics Uber operates a global two-sided marketplace , connecting riders, couriers, and freight shippers with independent drivers without owning vehicles or inventory.

Yoong Onn Corporation Berhad (KLSE:YOCB , Ticker 5159) In the context of fluctuating consumer spending and changing retail trends, Yoong Onn Corporation Berhad (KLSE: YOCB) is establishing itself as a resilient entity in Malaysia’s home textiles sector. The company is currently trading at a significant discount compared to analyst fair value, providing potential investors with the opportunity for long-term capital growth, solid margins, and an increasing dividend yield.

Duopharma Biotech Bhd (KLSE: DPHARMA, ticker 7148) Healthcare – Pharmaceuticals / Biotech Investment Review Recommendation: HOLD (Initiated) Key Metrics Company Overview Duopharma Biotech Bhd is a leading pharmaceutical manufacturer in Malaysia, involved in the research, development, manufacturing, and distribution of generic and specialty pharmaceutical products. Its operations span: Ethical Classic : General therapeutic generics (e.g., cardiovascular, anti-infectives) Ethical Specialty : Bio-similars for oncology, renal, and metabolic diseases Consumer Healthcare (CHC) : Notable OTC brands like Champs, Flavettes, and Uphamol As of 2025, it exports to multiple countries and operates from 3 GMP-certified manufacturing facilities.